The Hospital Group of the Institut Curie is a private organization which contributes to the public health system. With its diagnostic (imaging, pathology, laboratory testing) and therapeutic (surgery, radiotherapy, medical treatments, support treatment) armory, it blends technology and care, and ensures national and international dissemination of medical innovations.
A pioneer in a number of conservative treatments, the Hospital is a reference center throughout the world for breast cancer, pediatric tumors, sarcomas, eye tumors and numerous advanced techniques such as oncogenetics and precision radiotherapy (curietherapy, proton therapy).

The Research Center of the Institut Curie is one of the most important in Europe and the largest in France dedicated to cancer research. It houses more than 80 joint Institut Curie - CNRS, Inserm or University research groups whose common goal is to increase knowledge and ameliorate patient management using state-of-the-art technology platforms.

The Translational Research Department spearheads translational research and forms a vital link between basic research and healthcare, thus expediting transfer of scientific innovations from bench to bedside. It is developing new diagnostic techniques and more effective and safer approaches to treatment.

The Institut Curie has a Scientific Advisory Board whose remit is to guide its research policy and validate scientific choices. The Board's members are internationally recognized leaders in research and medicine.

Various departments ensure that the Institut Curie runs smoothly: financial management, development, communications, fundraising, legal, working hand in hand with the institutional services.